Lizz van der Heijden (L van der Heijden)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Prognostic Factors

Sensitive Detection

Top Venues

Journal of surgical oncology

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Lizz van der Heijden, Geert Spierenburg, Joseph K Kendal, Nicholas M Bernthal, Michiel Adreanus van de Sande
Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets. Journal of surgical oncology 128 (3) (2023)
Geert Spierenburg, Lizz van der Heijden, Kirsten van Langevelde, Károly Szuhai, Judith V M G Bovée, Michiel Adreanus van de Sande, André B P van Kuilenburg
Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches. Expert opinion on therapeutic targets 26 (4) (2022)
Kirsten van Langevelde, Arjen H G Cleven, A Navas Cañete, Lizz van der Heijden, Michiel Adreanus van de Sande, André B P van Kuilenburg, Judith V M G Bovée
Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective. Sarcoma 2022 (2022)
Sarah E Bosma, Lizz van der Heijden, Luis Sierrasesúmaga, Hans J H M Merks, Lianne M Haveman, Michiel Adreanus van de Sande, Mikel San-Julián
What Do We Know about Survival in Skeletally Premature Children Aged 0 to 10 Years with Ewing Sarcoma? A Multicenter 10-Year Follow-Up Study in 60 Patients. Cancers 14 (6) (2022)
Geert Spierenburg, Lizz van der Heijden, Monique Josephine Mastboom, Kirsten van Langevelde, Robert J P van der Wal, André B P van Kuilenburg, Michiel Adreanus van de Sande
Surgical management of 144 diffuse-type TGCT patients in a single institution: A 20-year cohort study. Journal of surgical oncology 126 (6) (2022)